The Intriguing History of Cancer Immunotherapy.
Dobosz P, Dzieciątkowski T. · 2019
Read The Intriguing History of Cancer Immunotherapy. by Dobosz P, Dzieciątkowski T. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6928196.txt.
Description
Dobosz and Dzieciątkowski trace the long history of treating cancer with the immune system. Their article appeared in Frontiers in Immunology. Immunotherapy feels like a recent breakthrough. Its roots reach back to antiquity. German physicians Fehleisen and Busch first noted tumours shrinking after severe skin infections.
William Coley built on those cases in 1891, trying to turn infection against bone cancer. His work was largely ignored for over fifty years. Later landmarks, such as the finding of T cells in 1967, rebuilt the field. The account ends with the 2018 Nobel Prize for checkpoint research. That work led to checkpoint inhibitors, CAR T-cells, and oncolytic viruses now in use.
Catalog record
| CREATOR | Dobosz P, Dzieciątkowski T. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |